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Abstract
Background
Primary care practitioners (PCP) play key roles in cervical cancer prevention. Human papil-
lomavirus (HPV) knowledge is an important influence on PCPs’ cervical cancer prevention-
related behaviours. We investigated HPV knowledge, and associated factors, among gen-
eral practitioners (GPs) and practice nurses.
Methods
A survey, including factual questions about HPV infection and vaccination, was mailed to
GPs and practice nurses in Ireland. Multivariable logistic regression was used to determine
which PCPs had low knowledge (questions correctly answered: infection�5/11; vaccina-
tion:�4/10). Questions least often answered correctly were identified.
Results
697 PCPs participated. For HPV infection, GPs and practice nurses answered a median of
nine and seven questions correctly, respectively (p<0.001). Significantly associated with
low HPV infection knowledge were: being a practice nurse/male GP; working fewer hours/
week; not having public patients; and having never taken a cervical smear. For HPV vacci-
nation, both GPs and practice nurses answered a median of six questions correctly (p =
0.248). Significantly associated with low HPV vaccination knowledge were: being a practice
nurse/male GP; working more years in general practice, fewer hours/week, in a smaller
practice or in a practice not specialising in women’s health; and having never taken a smear.
Six HPV infection questions, and seven HPV vaccination questions, were not answered cor-
rectly by > of PCPs.
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Conclusions
There are important limitations in HPV infection and vaccination knowledge among PCPs.
By identifying factors associated with poor knowledge, and areas of particular uncertainty,
these results can inform development of professional education initiatives thereby ensuring
women have access to uniformly high-quality HPV-related information and advice.
Introduction
The causal relationship between cervical cancer and “high-risk” human papillomavirus (HPV)
infection is reshaping cervical cancer prevention strategies internationally [1]. Primary care
practitioners (PCPs), both doctors and nurses, play key roles in cervical cancer prevention in
many countries. In the UK and Ireland, for example, they take most cervical screening tests.
Traditionally this has involved conducting cervical cytology tests, but some countries have
moved to, and others intend to implement, screening based on HPV testing, with the HPV test
provided to women in the same way as a cytology test. In addition, PCPs may also advise
patients about HPV infection or vaccination and/or provide HPV vaccination [2,3].
PCPs can significantly impact women’s cervical cancer prevention behaviours. They may
positively or negatively influence women’s screening participation decisions and decision-
making around HPV vaccination [4–6]. For example, US studies consistently show that health
professional recommendation is one of the strongest influences on parental decisions regard-
ing HPV vaccination of their children [7,8]. However, in theoretically-robust research, we
found that lack of HPV knowledge among PCPs was a key barrier to them performing cervical
cancer prevention-related behaviours appropriately [2]. Other studies indicate that practition-
ers with greater knowledge are more likely to discuss or recommend HPV vaccination [9–13].
Furthermore, in a recent US study, HPV vaccine initiation and completion rates among ado-
lescents were higher in the practice populations of primary care physicians with greater HPV
infection and vaccination knowledge [14]. Therefore, good knowledge appears a prerequisite
for optimal cervical cancer prevention-related behaviours among PCPs.
The success of the new prevention strategies also requires that women (and the wider popu-
lation) are adequately informed about HPV, understand new protocols/programmes, and find
them acceptable. However, public awareness of HPV is poor, understanding is limited, and
misconceptions are common [15–18]. Women regard PCPs as trusted sources of HPV-related
information and support [19–21]. Knowledgeable PCPs are, therefore, essential to effectively
meet people’s HPV information and advice needs.
Previous research suggests some PCPs have significant gaps in their HPV-related knowl-
edge [22–28]. However, most evidence is from North America and there has been very little
investigation of primary care nurses’ knowledge. We investigated HPV knowledge among pri-
mary care doctors and nurses; determined which PCPs have poor knowledge; and identified
particular aspects of HPV knowledge about which PCPs are most uncertain. Specifically, we
set out to compare whether knowledge levels of GPs and practice nurses vary, and whether
male and female GPs have different levels of knowledge; some tentative indications of this
emerged in our previous qualitative work [2]. Such information is essential to inform develop-
ment and targeting of professional education strategies, and ensure women receive the most
appropriate advice and support.
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Methods
Setting
The study setting was Ireland, which has a mixed public-private healthcare system. Citizens
pay for primary care services unless they possess a medical card, eligibility for which is based
on means and age. General practitioners (GPs) may choose whether to include medical card
holders (“public patients”) on their patient list. The cervical screening programme, Cervical-
Check, began national roll-out in 2008 and provides women aged 25–60 with free cytology
tests every 3–5 years [29]. Women may also obtain cytology tests privately from a GP or Well
Woman Centre. At the time of the fieldwork, HPV testing was available privately in primary
care. HPV vaccinations have been available privately in primary care since 2006 and a pub-
licly-funded schools-based vaccination programme for girls aged 12 commenced in 2010 [30].
Design
During May-August 2011, we conducted a cross-sectional postal survey of GPs and practice
nurses.
Study population
In total 1760 practitioners (880 GPs and 880 practice nurses) were sampled to be invited to
take part in the survey. The GP sampling frame was the Irish Medical Directory, which is Ire-
land’s most comprehensive listing of healthcare professionals. Simple random sampling was
used to select the sample. Since there is no national practice nurse register, half of the nurse
sample was selected, using simple random sampling, from a list of members of the Irish Prac-
tice Nurses Association and half from practice nurses registered with CervicalCheck. All of the
individuals on both nurse sampling frames were female.
Statistical power
Sample size was based on statistical power to detect, as significant, associations between a per-
sonal or practice-related characteristic or cervical screening-related behaviour and risk of low
HPV knowledge. “Low” knowledge was defined as the lowest quintile of respondents; we
aimed for�100 practitioners in this group. Assuming the characteristic had a prevalence of
25%, 100 respondents with a “low” score and 400 with a “higher” score would have 82% power
to detect, as statistically significant, an odds ratio of 2.0 (alpha = 0.05, two-sided test). Based on
assumption that the response rate would be 30% (consistent with other PCP surveys in Ire-
land), and allowing for some practitioners not being contactable, we decided to sample 1760
practitioners, evenly split between GPs and practice nurses.
Questionnaire
The questionnaire was 12 pages long, including the front and back cover and the embedded
consent form; a copy is available from the corresponding author on request. Content was theo-
retically informed based on findings from our qualitative work [2]. The sections were ordered
as follows: practitioners’ cervical screening behaviours; HPV infection-related attitudes,
beliefs, behaviours and knowledge; HPV vaccination-related attitudes, beliefs, behaviours and
knowledge; HPV testing-related attitudes and beliefs; three clinical scenarios regarding HPV;
and practitioners’ personal and practice characteristics. HPV infection knowledge was assessed
using 11 factual statements based on Jain et al [20]. Ten factual statements about HPV vaccina-
tion were developed using evidence-based information from sources including the European
Predicting poor HPV knowledge among primary care practitioners
PLOS ONE | https://doi.org/10.1371/journal.pone.0208482 December 13, 2018 3 / 15
Cervical Cancer Association (ECCA) and the National Immunisation Office Ireland. Response
options for each statement were agree, disagree and unsure.
Data collection
We used several strategies that have been shown to increase response rates to postal surveys
[31]. Subjects were sent a personalised pre-contact letter stating that they would shortly receive
a survey. A few indicated that they did not wish to receive the survey; for a few others, letters
were returned undelivered or marked that the recipient no longer practiced. These practition-
ers were removed and the survey was mailed, with a personalised cover letter, to 876 GPs and
866 practice nurses. The questionnaire and cover letter indicated that respondents would be
entered into a prize draw to win a high-street voucher. Non-respondents were sent a postal
reminder after two weeks followed, if required, by a telephone call two weeks later.
Ethics
Ethical approval was provided by the Irish College of General Practitioners (ICGP). The ICGP
Ethics Committee has responsibility for reviewing and approving research in primary care in
Ireland.
Statistical analysis
Practitioners were included in the analysis if they had answered at least half of the HPV infec-
tion or HPV vaccination factual questions. Two knowledge scores, one for infection and one
for vaccination, were generated for each participant comprising the number of correctly
answered questions. Correct/incorrect answers were defined based on what was known about
HPV infection and vaccination at the time of the fieldwork. Hence, if an individual answered 8
of the 11 HPV infection questions, and their responses to 5 of these were correct, their infec-
tion knowledge score was 5 out of a possible 11. Similarly if they answered all 11 HPV infection
questions and responses to 5 were correct, their knowledge score was 5/11.
Respondents’ personal and practice characteristics were summarised in terms of numbers
and percentages or means (with standard deviations) overall and for GPs and practice nurses
separately. The knowledge score distributions were skewed so we summarised average scores
for GPs and practice nurses in terms of medians and compared GPs’ and practice nurses’
knowledge score distributions using the non-parametric Wilcoxson rank-sum test. Practition-
ers with scores in the lowest quintile of the overall distribution were designated as having
“low” knowledge. Multivariable logistic regression was used to identify factors associated with
low knowledge, separately for infection and vaccination. Practitioners’ personal and practice
characteristics and cervical screening behaviours (Table 1) were considered for inclusion in
the models. Those significant on likelihood ratio tests (p<0.05) were retained in the final mod-
els. Following this, responses to individual questions were classified as “correct” or “incorrect”;
the latter group included those who provided wrong answers, indicated they were unsure of
the answer or declined to answer. Using chi-square tests, we tested for associations between
correct/incorrect answers and practitioner group (female GPs/male GPs/practice nurses). A
secondary analysis distinguished between wrong, unsure and missing responses.
Results
697 PCPs participated (response rate 40%; GPs: 238 (27% response); practice nurses: 459
(53%)). Table 1 shows practitioners’ personal and practice characteristics and cervical screen-
ing behaviours. All participating practice nurses, and 61% of GPs, were female.
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Table 1. Personal and practice characteristics, and cervical screening related behaviours, of PCPs who participated in the survey, numbers and percentages (or
means and standard deviation)1.
All PCPs GPs Practice Nurses
Total 697 100.0% 238 34.1% 459 65.9%
Personal characteristics
Sex Female 604 86.7% 145 60.9% 459 100.0%
Male 93 13.3% 93 39.1% 0 0.0%
Number of hours worked per week: mean (sd) 29.1 (12.2) 37.6 (14.1) 25.0 (8.7)
Number of years in general practice <10 years 298 43.4% 32 13.9% 266 58.3%
10–19 years 244 35.6% 78 33.9% 166 36.4%
20–39 years 135 19.7% 112 48.7% 23 5.0%
40+ years 9 1.3% 8 3.5% 1 0.2%
Ever worked or trained outside Ireland Yes 366 53.6% 118 51.1% 248 54.9%
No 317 46.4% 113 48.9% 204 45.1%
Practice characteristics
Practice location Dublin city 141 20.7% 52 22.7% 89 19.6%
A city other than Dublin 76 11.1% 24 10.5% 52 11.5%
A town 316 46.3% 102 44.5% 214 47.2%
A village 124 18.2% 44 19.2% 80 17.7%
Other country 25 3.7% 7 3.1% 18 4.0%
Solo GP practice Yes 118 17.3% 42 18.4% 76 16.7%
No 566 82.7% 186 81.6% 380 83.3%
Number of GPs in practice: mean (sd) 3.3 (2.1) 3.2 (2.2) 3.3 (2.1)
Any female GP(s)in practice Yes 559 81.7% 200 87.7% 359 78.7%
No 125 18.3% 28 12.3% 97 21.3%
Any practice nurse(s) in practice2 Yes 181 79.4% 181 79.4% -
No 47 20.6% 47 20.6% -
Practice has public patient list3 Yes 662 95.9% 214 92.6% 448 97.6%
No 28 4.1% 17 7.4% 11 2.4%
Practice specialises in women’s health Yes 448 65.6% 155 66.8% 293 65.0%
No 235 34.4% 77 33.2% 158 35.0%
Cervical screening-related behaviours
Registered smeartaker4 Yes 651 94.2% 212 91.4% 439 95.6%
No 40 5.8% 20 8.6% 20 4.4%
Number of cytology tests taken now compared to three years ago I take about the same 87 12.9% 47 20.6% 40 8.9%
I take fewer 91 13.5% 81 35.5% 10 2.2%
I take more 471 69.7% 89 39.0% 382 85.3%
I have never taken a smear 27 4.0% 11 4.8% 16 3.6%
Attended smeartaking seminar in past year Yes 327 47.9% 61 26.8% 266 58.5%
No 356 52.1% 167 73.2% 189 41.5%
Attended HPV seminar in past year Yes 106 16.4% 30 13.5% 76 17.9%
No 540 83.6% 192 86.5% 348 82.1%
1 subjects with missing values for each variable not shown so numbers may not sum to 697; % are of those who responded to the question
2 questions relevant to GPs only
3 i.e. patients with medical cards, which provide free primary care services and subsidized prescription medicines
4 registered with CervicalCheck, the national cervical cancer screening programme
https://doi.org/10.1371/journal.pone.0208482.t001
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HPV infection
Knowledge score distribution. Of the 690 practitioners who answered at least half the
questions, there were four (0.6%) who either answered zero or one question correctly, and 28
(4%) who answered all 11 questions correctly.
The median number of correctly answered questions was eight. GPs answered more ques-
tions correctly than practice nurses (Fig 1(A); GP median = 9; practice nurse median = 7; Wil-
coxson rank-sum p<0.001).
Factors associated with low knowledge. In the multivariable model, male GPs and prac-
tice nurses were significantly more likely than female GPs to have a low HPV infection knowl-
edge score (Table 2). Practitioners who had never taken a cervical cytology test (n = 27), or
who took more or fewer of these now than three years ago, had increased likelihood of low
knowledge. The likelihood of low knowledge was significantly lower among practitioners
whose practice had a public patient list and who worked more hours per week.
Questions least often answered correctly. Four HPV infection questions (relating to:
HPV infection in men increasing risk for anogenital cancers; HPV types associated with cervi-
cal cancer and genital warts; location of genital warts and cancer risk; and duration of HPV
infection) were not answered correctly by almost half of practitioners (Table 3). More practi-
tioners responded that they were unsure than provided a wrong answer (S1 Table). Two fur-
ther questions were not answered correctly by at least a third of practitioners (HPV infection
causes genital warts: 39% answered incorrectly; clearance of HPV infection: 33% answered
incorrectly). More practitioners gave the wrong answer than indicated that they were unsure
(S1 Table). For nine questions, female GPs, male GPs and practice nurses differed significantly
in the percentage who answered correctly (Table 3).
HPV vaccination
Knowledge score distribution. For HPV vaccination, of the 687 practitioners who
answered at least half the questions, 10 (1.5%) answered zero or one question correctly and six
(0.9%) answered all 10 correctly. The median number of questions answered correctly was six.
There was no difference between GPs and practice nurses (Wilcoxson rank-sum p = 0.248; Fig
1(B)).
Factors associated with low knowledge. For HPV vaccination, the likelihood of a low
knowledge score was significantly higher in male GPs and practice nurses than female GPs
(Table 2). It was significantly lower with more weekly hours worked and more GPs in the prac-
tice, and significantly higher with more years in general practice.
Fig 1. Distribution of HPV infection and vaccination knowledge scores among GPs and practice nurses. (A) HPV infection
knowledge. (B) HPV vaccination knowledge.
https://doi.org/10.1371/journal.pone.0208482.g001
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Practitioners whose practice specialised in women’s health were less likely to have low
knowledge, while those who had never taken a cervical cytology test, or took fewer now than
previously, were more likely to have low knowledge.
Questions least often answered correctly. For HPV vaccination, three questions were
not answered correctly by more than half of practitioners (Table 3). These related to: percent-
age of cervical cancers likely to be prevented by vaccination (74% answered incorrectly);
whether vaccination offers protection against other cancers (67% answered incorrectly); and
whether HPV vaccines are licensed for use in boys (51% answered correctly). For the first,
more practitioners answered wrongly than were unsure; for the other two more were unsure
than answered wrongly (S1 Table). A further four questions were not answered correctly by
between 31% and 45% of respondents. For three of these, more practitioners were unsure than
Table 2. Significant predictors of low HPV knowledge, numbers and percentages with low scores1, multivariable odds ratios (OR) with 95% confidence intervals
(CI), and p values for point estimates and from likelihood ratio tests (LRT).
Low score OR 95%CI p2 LRT p3
No. %
HPV infection Practitioner type and gender
Female GP 5 4.2 1 - - -
Male GP 13 16.3 5.95 1.69 20.98 0.006
Practice Nurse 93 21.8 5.75 2.13 15.49 0.001 <0.001
Hours worked per week4 - - 0.95 0.94 0.98 0.000 <0.001
Practice has public patient list
No 68 21.1 1.00 - - -
Yes 43 14.2 0.46 0.29 0.73 0.001 0.001
Number of cervical cytology test taken now compared to three years ago
I take about the same 4 5.1 1.00 - - -
I take fewer 12 15.0 5.72 1.48 22.15 0.012
I take more 83 18.8 3.71 1.27 10.87 0.017
I have never taken a smear 12 48.0 10.56 2.71 41.12 0.001 0.002
HPV vaccination Practitioner type & gender
Female GP 8 6.7 1 - - -
Male GP 26 32.9 3.92 1.34 11.43 0.013
Practice Nurse 84 20.4 4.63 1.86 11.52 0.001 <0.001
Hours worked per week2 - - 0.98 0.95 1.00 0.032 0.030
Years worked in general practice3 - - 1.05 1.02 1.08 0.003 0.002
Number of GPs in practice4 - - 0.87 0.77 0.99 0.030 0.023
Practice specializes in women’s health
No 58 28.2 1 - - -
Yes 60 14.9 0.60 0.39 0.94 0.027 0.028
Number of cervical cytology test taken now compared to three years ago
I take about the same 6 8.0 1 - - -
I take fewer 23 28.8 4.39 1.43 13.47 0.010
I take more 76 17.7 2.11 0.84 5.27 0.110
I have never taken a smear 13 52.0 8.51 2.53 28.69 0.001 0.002
1 defined as answering�5 HPV infection, or�4 HPV vaccination, questions correctly
2 p value for point estimate (i.e. test of difference of OR from 1)
3 p value from likelihood ratio test of contribution of variable to multivariate model.
4 OR per unit increase
https://doi.org/10.1371/journal.pone.0208482.t002
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Table 3. Responses to individual HPV infection and vaccination knowledge questions for all practitioners, and by practitioner group, with p values from chi-square
tests for association between group and whether response was correct1.
Statement All PCPs Practitioner Group
Female GPs Male GPs Practice nurses p-value
Correct Incorrect2 Correct Incorrect2 Correct Incorrect2 Correct Incorrect2
HPV infection
a. Genital HPV infection is fairly common in sexually active
adults (True)
82.8% 17.2% 91.6% 8.4% 80.4% 19.6% 80.4% 19.6% p = 0.007
b. A person with genital HPV infection may never show
symptoms of infection (True)
91.6% 8.4% 99.3% 0.7% 94.6% 5.4% 88.6% 11.4% p<0.001
c. Most genital HPV infections may be cleared without
medical intervention (True)
67.1% 32.9% 76.2% 23.8% 54.3% 45.7% 66.8% 33.2% p = 0.002
d. Persistent genital HPV infections in women increase the
risk of cervical dysplasia and cervical cancer (True)
93.9% 6.1% 95.8% 4.2% 93.5% 6.5% 93.4% 6.6% p = 0.569
e. Genital HPV infection in men increases risk of penile and
other anogenital cancers (True)
52.8% 47.2% 67.8% 32.2% 72.8% 27.2% 44.0% 56.0% p<0.001
f. Treatment of cervical dysplasia/cancer always permanently
eliminates the causative infection (False)
76.7% 23.3% 86.0% 14.0% 82.6% 17.4% 72.5% 27.5% p = 0.001
g. Genital HPV infection causes external anogenital warts
(True)
61.2% 38.8% 81.8% 18.2% 73.9% 26.1% 52.1% 47.9% p<0.001
h. Genital HPV types usually associated with external
anogenital warts differ from types usually associated with cervical
dysplasia and cervical cancer (True)
51.4% 48.6% 64.3% 35.7% 43.5% 56.5% 49.0% 51.0% p = 0.002
i. External anogenital warts increase risk of cancer at the same
site where the warts are located (False)
51.9% 48.1% 56.6% 43.4% 41.3% 58.7% 52.5% 47.5% p = 0.064
j. Treatment of external anogenital warts always permanently
eliminates the causative infection (False)
78.8% 21.2% 92.3% 7.7% 83.7% 16.3% 73.6% 26.4% p<0.001
k. Available tests and procedures can determine the duration
of a patient’s genital HPV infection (False)
53.3% 46.7% 67.8% 32.2% 57.6% 42.4% 47.9% 52.1% p<0.001
HPV vaccination
a. HPV vaccination gives lifelong protection against cervical
cancer (False)
55.2% 44.8% 51.0% 49.0% 38.0% 62.0% 59.0% 41.0% p<0.001
b. HPV vaccines are live vaccines (False) 69.1% 30.9% 72.7% 27.3% 57.6% 42.4% 69.5% 30.5% p = 0.028
c. HPV vaccination is generally less effective in sexually active
girls/women (True)
65.4% 34.6% 72.0% 28.0% 63.0% 37.0% 62.7% 37.3% p = 0.114
d. HPV vaccination will prevent >90% of cervical cancers
(False)
25.8% 74.2% 28.7% 71.3% 17.4% 82.6% 26.1% 73.9% p = 0.126
e. HPV vaccines contain no viral DNA and are not infectious
or oncogenic (True)
64.6% 35.4% 76.2% 23.8% 60.9% 39.1% 60.6% 39.4% p = 0.003
f. Available HPV vaccines protect against all of the HPV types
that can cause cervical cancer (False)
76.4% 23.6% 81.8% 18.2% 76.1% 23.9% 73.4% 26.6% p = 0.148
g. HPV vaccination may protect against other types of cancer
in addition to cervical cancer (True)
32.6% 67.4% 53.8% 46.2% 50.0% 50.0% 21.8% 78.2% p<0.001
h. Available HPV vaccines are not licensed for use in
adolescent boys in Ireland (True)
49.3% 50.7% 46.9% 53.1% 29.3% 70.7% 53.4% 46.6% p<0.001
i. Vaccinated females will no longer need to have smears
(False)
95.3% 4.7% 95.8% 4.2% 91.3% 8.7% 94.3% 5.7% p = 0.134
j. All available HPV vaccines protect against genital warts
(False)
71.3% 28.7% 80.4% 19.6% 57.6% 42.4% 69.9% 30.1% p = 0.001
1 test of association between practitioner group (female GP/male GP/practice nurse) and whether or not they answered the question correctly (correct/incorrect);
whether the statement is true or false is indicted in brackets following each statement
2 includes subjects who provided the wrong answer, who indicated that they were unsure, and who declined to answer
https://doi.org/10.1371/journal.pone.0208482.t003
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provided the wrong answer (S1 Table). The frequency of correct answers varied significantly
between female GPs, male GPs and practice nurses for eight questions (Table 3).
Discussion
This study investigated HPV knowledge among PCPs in order to inform professional educa-
tion strategies around HPV. Overall, PCPs correctly answered a median of eight of 11 factual
HPV infection questions and six of 10 HPV infection questions. While these figures are not
especially low, they conceal important patterns. Notably, practice nurses’ and male GPs’
knowledge levels were significantly lower than female GPs’. Moreover, large proportions of
PCPs were wrong or uncertain about several key aspects of HPV-related knowledge.
HPV knowledge levels over time and internationally
Past studies revealed gaps in PCPs’ HPV knowledge [22–28]. Several of these were conducted
before the introduction of HPV vaccination programmes and incorporation of HPV testing
into screening, and knowledge may have improved since then. For example, in a 2007 GP sur-
vey in Ireland, only 10% of GPs were aware that HPV vaccination may protect against other
cancers [32]; this had risen to around 50% in the current survey. However, in the current
study, only one in five practice nurses were aware HPV vaccination may protect against other
cancers. At the time of our survey, the HPV vaccination programme was in its first year and
the national cervical screening programme was completing its first screening round. The sug-
gestion that significant knowledge gaps may remain despite public health developments
around HPV is echoed in two recent studies [27,28]. A survey of primary healthcare profes-
sionals in Norway, conducted one year after the introduction of HPV vaccination among
school-girls, and a survey of primary care practice nurses in England conducted several years
after the HPV vaccination programme commenced and use of HPV testing was incorporated
into the national screening programme, both revealed limitations in practitioners’ knowledge.
Conclusions of other studies of PCPs’ HPV-related knowledge vary. In one study in Hong
Kong, most doctors, nurses and smear-taker trainees had only basic HPV knowledge [33]. In
another study, also in Hong Kong, less than half of doctors knew what percentage of cervical
cancer is caused by HPV [34]. In contrast, an Australian study reported that GPs have good
HPV vaccination knowledge [35]. This indicates the importance of conducting such surveys in
settings with different cervical cancer prevention strategies.
Variations in knowledge between GPs and practice nurses
Our observation that male GPs were more likely to have low HPV knowledge than female GPs
is novel. Male GPs may be less interested in the topic of HPV, perceiving it to be a “women’s
issue” or related to taking smears which, in Ireland at least, is viewed as a female role [2]. Nota-
bly, the only question answered correctly by a greater proportion of male than female GPs con-
cerned the role of HPV in penile and other anogenital cancers. In addition, participating male
GPs were sufficiently interested in the topic of cervical cancer prevention to take part. This
suggests they may have a better HPV knowledge than the overall population of male GPs [31].
The rationale for the study was theoretically-robust evidence that HPV knowledge is an
important predictor of practitioners’ HPV-related clinical behaviours [2] and may influence
the quality of advice provided to patients. The concern these results raise is that women who
attend male GPs may not receive the highest quality advice. There is a need, therefore, to
ensure that any professional development initiatives seek to fully engage male GPs. More wide-
spread recognition of the importance of HPV in cancers at sites other than the female genital
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tract, and in various benign but common conditions [36,37], may suggest a route through
which to engage male GPs with the topic.
Similar to the UK and Australia, practice nurses in Ireland are increasingly delegated the
task of taking screening tests [38]. This provides them with opportunities to discuss HPV
infection and vaccination with patients. It is worrying, therefore, that practice nurses had
lower average HPV infection knowledge scores than GPs and, although median HPV vaccina-
tion scores did not differ, for every HPV vaccination question more nurses than female GPs
failed to answer correctly. Only two previous studies, the first of 154 practitioners in New Zea-
land, and the second of 220 practitioners in Norway, appear to have compared GPs’ and pri-
mary care nurses’ knowledge [27,39]. In the New Zealand survey, GPs more often correctly
answered each of five HPV infection questions. In the Norwegian study, GPs were more
knowledgeable about the causal relationship between HPV and cancer and, although nurses
knew more about other aspects of HPV than GPs, there were still significant limitations in
nurses’ knowledge. These results, and ours, reinforce the need to include practice nurses in
any future HPV-related education initiatives.
Other factors associated with HPV infection and vaccination knowledge
Several factors associated with HPV infection knowledge were also related to HPV vaccination
knowledge. This was unsurprising given that infection and vaccination knowledge levels were
significantly correlated.
Several “practice”-related factors were significantly associated with low scores, especially for
HPV vaccination. GPs’ factual medical knowledge may decline with age and full-time practi-
tioners tend to have higher knowledge scores than part-time practitioners [40]. The observed
associations between low HPV knowledge and working more years in general practice and
working fewer hours per week are probably due to this. Older practitioners, who trained when
there was less emphasis on continuing medical education (CME), may be less likely to keep
up-to-date with medical developments, and those who work fewer hours may have less oppor-
tunity to do so. Working in a smaller practice was significantly associated with low HPV vacci-
nation knowledge. Practitioners in smaller practices may be more isolated from recent
developments or less likely to attend CME or other training events. They may also receive
fewer visits from representatives of the HPV vaccine manufacturers. The association between
low knowledge and never having taken a smear was unsurprising. Practitioners who take
smears for the screening programme are encouraged to attend training and information ses-
sions provided by CervicalCheck, some of which cover HPV.
Specific limitations in knowledge
We assessed HPV infection knowledge using questions developed in Jain et al. [22]. For most
questions, a higher percentage of the 368 US family physicians in that study (who were sur-
veyed in 2004) provided correct answers than the PCPs in our study. Two exceptions were the
questions on whether infection may clear without treatment and whether genital warts
increase cancer risk at the site of the wart; both questions were answered correctly by more
PCPs in the current study but high proportions still failed to provide a correct answer (33%
and 48% respectively). Moreover, around half of practitioners in both settings were unable to
correctly answer a question about whether the same HPV types are associated with genital
warts and cervical dysplasia. A subsequent US study reported low awareness among physicians
that HPV vaccination may prevent vaginal, vulvar and anal cancer [41]. Similarly, in our
study, two-thirds of practitioners were unable to correctly answer a question about this. Less
than 20% of healthcare providers in China knew that sexually naive women are the most
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appropriate population for HPV vaccination [42]. The percentage of correct answers to a simi-
lar question in the current study was higher, but one-third of practitioners failed to answer
correctly. The similarities in the findings of these studies suggest that practitioners in many
settings may be unclear about these aspects of HPV.
Implications
The observed gaps in HPV knowledge of PCPs are particularly concerning given the recom-
mended change to primary HPV-based screening in Ireland [43] (and similar changes under-
way or imminent elsewhere). There is an urgent need to develop professional education
initiatives for PCPs to ensure that they are well informed and that women have access to accu-
rate and high-quality HPV-related information and advice. If such initiatives are not provided,
it is possible that screening uptake might fall (because of the link between practitioners’ knowl-
edge and HPV-related behaviours [2,12]) or the psychological burden on women of having a
positive screening test might rise (since women consider PCPs trusted sources of HPV infor-
mation [19–21]). The study findings may be helpful in terms of targeting such initiatives (e.g.
to practitioner groups with lower knowledge) and developing content (e.g. focusing on areas
of HPV were knowledge gaps are greatest). Since PCPs’ have many competing priorities, edu-
cational resources might be provided in different formats so that PCPs can access these in a
format, and at times, that suits them. In terms of incentives, training and education events
could have CME accreditation. It may also be worth considering whether completion of, for
example, a HPV education course should a pre-condition of being approved as a screening
provider by the screening programme.
From a research perspective, although knowledge per se is a key determinant of physicians
undertaking cervical cancer prevention behaviours [2,12], it remains unclear which specific
aspects of HPV knowledge are related to provision of appropriate HPV information or advice,
HPV tests or other HPV-related clinical behaviours. To underpin development of effective
professional educational initiatives, research is needed to better understand which individual
aspects of knowledge drive specific behaviours.
Strengths and limitations
Low response rates by PCPs to mailed surveys are common, and our response rate (40%) is
consistent with those typically reported [44]. We do not know why PCPs did not take part and
can only speculate that reasons may include lack of interest in the topic, other priorities, or
lack of time. As with any survey, it is possible that participants’ knowledge levels differ from
those of the populations from which they were drawn. Participating GPs’ characteristics were
similar to those of all GPs in the Irish Medical Directory, with the exception of gender; female
GPs were over-represented among survey participants. Other than knowing that they were all
female, we had no data on characteristics of the nurses comprising the sampling frames. The
data collection was in 2010, and that is a limitation. We cannot be certain about current knowl-
edge levels. If the survey was repeated now knowledge levels may be higher as practitioners
have become more familiar with these screening and vaccination programmes. Alternatively,
they may have fallen; HPV was considered a “hot topic” at the time of the survey and this may
have placed it at the forefront of practitioners’ minds.
Conclusions
There are important limitations in PCPs’ HPV infection and vaccination knowledge particu-
larly among male GPs and practice nurses. Characteristics of practitioners most likely to need
support, and specific aspects of HPV-related knowledge about which practitioners are most
Predicting poor HPV knowledge among primary care practitioners
PLOS ONE | https://doi.org/10.1371/journal.pone.0208482 December 13, 2018 11 / 15
often uncertain or incorrect, have been identified. The results can inform development of pro-
fessional education initiatives to ensure that women have access to uniformly high-quality
HPV information and advice.
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